Asmanex FDA Approval History
FDA Approved: Yes (First approved March 30, 2005)
Brand name: Asmanex
Generic name: mometasone furoate
Dosage form: Inhalation Powder
Company: Schering-Plough Corporation
Treatment for: Asthma
Asmanex Twisthaler (mometasone furoate) is an inhaled corticosteroid for the treatment of asthma.
Development timeline for Asmanex
| Date | Article |
|---|---|
| Feb 4, 2008 | Approval FDA Approves Asmanex Twisthaler (Mometasone Furoate InhalationPowder) for the Once Daily Maintenance Treatment of Asthma inChildren Ages 4-11 |
| Mar 30, 2005 | Approval FDA Approves Asmanex Twisthaler for Asthma |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.